Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: The sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT)

Autor: Meliga, E., Garcia-Garcia, H.M., Valgimigli, M., Chieffo, A., Biondi-Zoccai, G., Maree, A.O., Gonzalo, N., Cook, S., Marra, S., Moretti, C., De Servi, S., Palacios, I.F., Windecker, S., van Domburg, R., Colombo, A., Sheiban, I., Serruys, P.W.
Zdroj: In International Journal of Cardiology 2009 137(1):16-21
Databáze: ScienceDirect